NightHawk Radiology Services announced its entry into the imaging interpretation quality assurance business at a scientific session Thursday at the ECR, arguing that it offers a more rigorous and objective system for evaluating the quality of radiologists’ work.
NightHawk Radiology Services announced its entry into the imaging interpretation quality assurance business at a scientific session Thursday at the ECR, arguing that it offers a more rigorous and objective system for evaluating the quality of radiologists’ work.
Although Europe is not its primary market for the service, NightHawk chief medical officer Dr. Timothy V. Meyers said the international exposure wouldn’t hurt the company. The primary market, he said after the session, is the U.S. and NightHawk has already started offering the service to some radiology practices. Further, although he did not mention it in the talk, NightHawk is hoping to carve away some of the quality assurance work now held by the ACR under its RadPeer program.
The title of the talk was “Beyond RadPeer: The next generation of quality assurance.”
Meyers described the NightHawk program and its experience in evaluating more than 2.1 million cases between May 1 and Dec. 31 of last year. A fraction of those cases (1.86%) were returned with discrepancy reports identified by the radiologists who performed final reads on preliminary reads provided by NightHawk radiologists.
“The Achilles heel of any (quality assurance program) is the underreporting of discrepancies,” Meyers said.
A program based on objective patient outcomes will result in fewer underreporting errors and a system that more accurately and objectively rates radiologists will be more easily accepted, he said.
The study broke the discrepancies into four categories and focused on two that were most likely to affect patient management. There were 5338 in those two categories (out of a total 38,623). A further review found that 2468 were valid, Meyer said.
Under questioning from a member of the audience, Meyers acknowledged that the program can’t assure that it is catching all discrepancies, since the actual reporting rate was only 1.86%, but he said NightHawk is making an effort to strengthen communications and reporting by radiologists who provide the final interpretations and discrepancy reports.
The company bases its evaluation on both the accuracy of the report and the quality, considering factors such as pertinence, clarity, and appropriate brevity. Data are collected by the radiologist who originates the report. Secondary reviews are carried out by an internal review board, the medical director, and the chief medical officer.
Standards at all levels are clear and avoid the ambiguity that can plague other systems, Meyer said.
“Avoiding subjective judgments decreases the insinuation of guilt associated with a misinterpretation,” he said. “This leads to better acceptance and an easier transition to a (quality improvement program) where collegial follow-up can occur.”
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.